The International Health Group is established to respond to the urgent need to combat HIV/AIDS, tuberculosis, and other threats to human health.
Founder and President Thurston F. Teele names his successor, Ashraf Rizk. In April 2002, Teele was appointed chairman of the board, and Rizk took over as president and CEO.
In an effort to help fight tuberculosis in the Philippines, Chemonics launches its first major stand-alone project in health care. The company also begins one of several large activities to revitalize agriculture and municipal services in Afghanistan.
Chemonics sponsors the U.S. Global Leadership Campaign as part of an increasing effort to promote the importance of U.S. foreign assistance. Simultaneously, the company launches an initiative to help agricultural producers in developing countries increase their competitiveness though better understanding of international grades and standards.
Chemonics builds on its emerging status as an international development leader with company-wide campaigns to share knowledge more broadly, train and support a new generation of development professionals, and formalize ethical and professional standards for international development work.
Founder Thurston F. Teele passes away on March 21 at age 70. After stepping down as president and CEO in 2001, Teele, who started Chemonics as a one-man business in 1975, had remained with the company as chairman of the board.
In May, 11 Afghans are killed in two separate attacks in southern Afghanistan. Among those killed are four Chemonics employees working on the USAID Alternative Incomes Project in Afghanistan’s Helmand province.
Senior Vice Presidents Susanna Mudge and Richard Dreiman are named executive vice presidents. The move is designed to allow Chemonics to be more responsive to the needs of its clients and project beneficiaries around the world.
On April 1, Richard Dreiman becomes Chemonics’ third president and CEO, succeeding Ashraf Rizk, who retires after 25 years of service. Rizk remains on Chemonics’ Board of Directors.
In September, ownership shifts following a transfer of shares to minority shareholder Eyk Van Otterloo from majority shareholder Scott Spangler. Van Otterloo becomes new chairman, and Barbara Teele is elected to the board.
Chemonics creates new corporate standards for project excellence. These standards are designed to elevate the level of service that the firm is able to provide and to maximize development impact and the return on donor investments.
Chemonics establishes a new regional division, Afghanistan and Pakistan. As well, the company integrates management of its health portfolio into its regional divisions, with the International Health Group providing technical leadership company-wide.